GBMA Education is the educational arm of the Generic and Biosimilar Medicines Association (GBMA), which is the representative body of generic and biosimilar medicine suppliers in Australia.
Sydney, Australia
Jatinder shares an international perspective on the use of biosimilar medicines in the UK.
Barry discusses the practicalities of introducing biosimilar medicines to the hospital formulary at Fiona Stanley Hospital.
David shares his insights into the role of hospital pharmacy and the use of biosimilar medicines.
Dr Ghaly shares his experience with the SAME study and his approach to counselling patients on biosimilar medicines.
Dr Thin discusses her involvement with the SAME study, a biosimilar infliximab switch study conducted in Australia.
A/Prof Östör shares his experience researching biosimilar medicines both here in Australia and in the UK.
Prof Clarke shares his knowledge and experience with the regulation and approval of biosimilar medicines in Australia.
Prof Sinclair shares his experience and thoughts about biosimilar medicines in the dermatological space.
Prof Zalcberg shares his thoughts on biosimilar medicines and their potential for greater treatment access in oncology.
Prof Szer shares his history and experience with biosimilar medicines in haematology.
Prof Bird brings a rheumatologist’s perspective to the discussion on biosimilar medicines and their practical implications.
Prof Murphy discusses how biosimilar medicines can contribute to the sustainability of the Australian healthcare system.
© 2020-2025 Ivy Podcast Discovery LLC
